Literature DB >> 25151008

Experimental mouse models of T cell-dependent inflammatory bowel disease.

George X Song-Zhao1, Kevin J Maloy.   

Abstract

Inflammatory bowel diseases (IBD) represent idiopathic chronic inflammatory disorders of the intestinal tract that are associated with aberrant immune responses against intestinal bacteria. Here, we describe two T cell-dependent models of experimental murine IBD. In the "T cell transfer" model, lymphopenic (scid or Rag (-/-) ) mice develop colitis upon adoptive transfer of naïve CD4(+) T cells. This model has also been extensively employed to identify mechanisms through which CD4(+)CD25(+) regulatory T cells suppress intestinal inflammation in vivo. We also describe a model of T cell-dependent IBD in immunocompetent mice, induced by infection with the intestinal bacterium Helicobacter hepaticus and concomitant treatment with a blocking αIL-10R mAb, which leads to the development of chronic inflammation of the caecum and colon (typhlocolitis). Both models reproduce many facets of human IBD pathology, including epithelial hyperplasia, goblet cell depletion, and leukocyte infiltration. These models provide reliable and tractable systems for the analyses of the induction and regulation of chronic inflammation in the gut.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25151008     DOI: 10.1007/978-1-4939-1212-4_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Immune-microbiota interactions in health and disease.

Authors:  Noah W Palm; Marcel R de Zoete; Richard A Flavell
Journal:  Clin Immunol       Date:  2015-06-30       Impact factor: 3.969

2.  Lack of Effect of Murine Norovirus Infection on the CD4+ CD45RBhigh T-cell Adoptive Transfer Mouse Model of Inflammatory Bowel Disease.

Authors:  Charlie C Hsu; Karuna Patil; Audrey Seamons; Thea L Brabb; Piper M Treuting; Jisun Paik; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2020-01-14       Impact factor: 0.982

3.  Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis.

Authors:  Haider Rasheed Alrafas; Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2019-12-11       Impact factor: 5.914

4.  Intestinal epithelial PKM2 serves as a safeguard against experimental colitis via activating β-catenin signaling.

Authors:  Xinlei Sun; Li Yao; Hongwei Liang; Dong Wang; Yueqin He; Yao Wei; Lei Ye; Kai Wang; Limin Li; Jiangning Chen; Chen-Yu Zhang; Guifang Xu; Fangyu Wang; Ke Zen
Journal:  Mucosal Immunol       Date:  2019-08-28       Impact factor: 7.313

5.  Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation.

Authors:  Lei Zhou; Wenqing Zhou; Ann M Joseph; Coco Chu; Gregory G Putzel; Beibei Fang; Fei Teng; Mengze Lyu; Hiroshi Yano; Katrin I Andreasson; Eisuke Mekada; Gerard Eberl; Gregory F Sonnenberg
Journal:  Nat Immunol       Date:  2022-01-31       Impact factor: 31.250

6.  Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3⁺ Treg cell function in the intestine.

Authors:  O J Harrison; N Srinivasan; J Pott; C Schiering; T Krausgruber; N E Ilott; K J Maloy
Journal:  Mucosal Immunol       Date:  2015-03-04       Impact factor: 7.313

7.  Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis.

Authors:  Isabelle C Arnold; Claire Hutchings; Ivanela Kondova; Ariann Hey; Fiona Powrie; Peter Beverley; Elma Tchilian
Journal:  Vaccine       Date:  2015-03-04       Impact factor: 3.641

8.  The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation.

Authors:  Agnieszka M Kabat; Oliver J Harrison; Thomas Riffelmacher; Amin E Moghaddam; Claire F Pearson; Adam Laing; Lucie Abeler-Dörner; Simon P Forman; Richard K Grencis; Quentin Sattentau; Anna Katharina Simon; Johanna Pott; Kevin J Maloy
Journal:  Elife       Date:  2016-02-24       Impact factor: 8.140

9.  Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.

Authors:  Alessandra De Riva; Maja Wållberg; Francesca Ronchi; Richard Coulson; Andrew Sage; Lucy Thorne; Ian Goodfellow; Kathy D McCoy; Miyuki Azuma; Anne Cooke; Robert Busch
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

Review 10.  Helminth Immunomodulation in Autoimmune Disease.

Authors:  Taylor B Smallwood; Paul R Giacomin; Alex Loukas; Jason P Mulvenna; Richard J Clark; John J Miles
Journal:  Front Immunol       Date:  2017-04-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.